Publication: The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis
Issued Date
2020-01-01
Resource Type
ISSN
14332965
0937941X
0937941X
Other identifier(s)
2-s2.0-85078891057
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Osteoporosis International. (2020)
Suggested Citation
W. Wongtrakul, N. Charoenngam, P. Ungprasert The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis. Osteoporosis International. (2020). doi:10.1007/s00198-020-05318-y Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/53848
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis
Author(s)
Other Contributor(s)
Abstract
© 2020, International Osteoporosis Foundation and National Osteoporosis Foundation. Background: Recent studies have suggested that irritable bowel syndrome (IBS) could be a risk factor for osteoporosis although the evidence is still limited. The current study aimed to comprehensively examine the risk of osteoporosis among patients with IBS using systematic review and meta-analysis technique. Methodology: Literature search was independently conducted by two investigators using MEDLINE, EMBASE, and Google Scholar database up to October 2019. Eligible study must evaluate whether patients with IBS have a higher risk of osteoporosis and/or osteoporotic fracture. It could be either cross-sectional study, case-control study, or cohort study. Point estimates and standard errors from each eligible study were combined together using the generic inverse variance method of DerSimonian and Laird. Results: Of the 320 articles identified from the three databases, four cohort and one cross-sectional study with 526,633 participants met the eligibility criteria and were included into the meta-analysis. All five studies investigated the risk of osteoporosis among patients with IBS, and the pooled analysis found that patients with IBS had a significantly higher risk of osteoporosis than individuals without IBS with the pooled risk ratio of 1.95 (95% CI, 1.04–3.64; I2 100%). Sensitivity analysis including only cohort studies found a lower RR (pooled RR 1.55; 95% CI, 1.39–1.72) with a lower I2 (59%). Three studies investigated the risk of osteoporotic fracture, and the pooled analysis found that patients with IBS also had a higher risk of osteoporotic fracture than individuals without IBS with the pooled risk ratio of 1.58 although statistical significance was not reached (95% CI, 0.95–2.62; I2 99%). Sensitivity analysis including only cohort studies found a lower RR (pooled RR 1.27; 95% CI, 1.20–1.39) with a dramatically lower I2 (0%). Limitations included high heterogeneity and reliance on diagnostic codes. Conclusion: A significantly increased risk of osteoporosis among IBS patients was observed in this study. Early intervention to prevent the development of osteoporosis, such as weight-bearing exercise, adequate intake of vitamin D and calcium, and early screening for osteoporosis, may be beneficial to these patients although further studies are still required to confirm the efficacy and cost-effectiveness of this approach.